Implementation Of Track, Trace System For Drug Formulation Exports Extended Till Feb 2024

New Delhi : The government on Friday extended the date for implementation
of the track and trace system for exports of drug formulations till February next year. The decision applies to both non-SSI (Small Scale Industry) and SSI-manufactured drugs.

“The date for implementation of track and trace system for exports of drug formulations with respect to maintaining the parent-child relationship in packaging levels and its uploading on central portal has been extended up to February 1, 2024 for both SSI and non-SSI manufactured drugs,” the Directorate General of Foreign Trade (DGFT) said in a public notice.

Earlier also, the dates have been extended from time to time.

The manufacturer or the exporter of drug formulations would have to print the barcode as per global standards at different packaging levels — primary, secondary and tertiary — to facilitate tracking and tracing of their products.

Barcode helps in tracking and tracing the origin of drugs, which minimises the chances of genuine medicines being considered spurious, sub-standard or counterfeit.

Related Posts

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Stem cell therapy for autism illegal: NMC advisory

New Delhi:  The National Medical Commission (NMC) issued a strict advisory on March 25, 2026, declaring stem cell therapy illegal for treating Autism Spectrum Disorder and cerebral palsy in routine…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha